P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS

Detalles Bibliográficos
Autores principales: Steiner, R., Strati, P., Flowers, C., Neelapu, S., Green, M., Nastoupil, L., Hagemeister, F., Feng, L., Ahmed, S., Nair, R., Fayad, L., Lee, H., Rodriguez, M. A., Westin, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430250/
http://dx.doi.org/10.1097/01.HS9.0000847752.29527.f6
_version_ 1784779709259710464
author Steiner, R.
Strati, P.
Flowers, C.
Neelapu, S.
Green, M.
Nastoupil, L.
Hagemeister, F.
Feng, L.
Ahmed, S.
Nair, R.
Fayad, L.
Lee, H.
Rodriguez, M. A.
Westin, J.
author_facet Steiner, R.
Strati, P.
Flowers, C.
Neelapu, S.
Green, M.
Nastoupil, L.
Hagemeister, F.
Feng, L.
Ahmed, S.
Nair, R.
Fayad, L.
Lee, H.
Rodriguez, M. A.
Westin, J.
author_sort Steiner, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9430250
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94302502022-08-31 P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS Steiner, R. Strati, P. Flowers, C. Neelapu, S. Green, M. Nastoupil, L. Hagemeister, F. Feng, L. Ahmed, S. Nair, R. Fayad, L. Lee, H. Rodriguez, M. A. Westin, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430250/ http://dx.doi.org/10.1097/01.HS9.0000847752.29527.f6 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Steiner, R.
Strati, P.
Flowers, C.
Neelapu, S.
Green, M.
Nastoupil, L.
Hagemeister, F.
Feng, L.
Ahmed, S.
Nair, R.
Fayad, L.
Lee, H.
Rodriguez, M. A.
Westin, J.
P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title_full P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title_fullStr P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title_full_unstemmed P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title_short P1222: PACIFIC: BRENTUXIMAB VEDOTIN AND NIVOLUMAB ALONE AND THEN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE FOR UNTREATED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PATIENTS
title_sort p1222: pacific: brentuximab vedotin and nivolumab alone and then combined with rituximab, cyclophosphamide, doxorubicin and prednisone for untreated primary mediastinal large b-cell lymphoma patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430250/
http://dx.doi.org/10.1097/01.HS9.0000847752.29527.f6
work_keys_str_mv AT steinerr p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT stratip p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT flowersc p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT neelapus p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT greenm p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT nastoupill p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT hagemeisterf p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT fengl p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT ahmeds p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT nairr p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT fayadl p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT leeh p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT rodriguezma p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients
AT westinj p1222pacificbrentuximabvedotinandnivolumabaloneandthencombinedwithrituximabcyclophosphamidedoxorubicinandprednisoneforuntreatedprimarymediastinallargebcelllymphomapatients

Ejemplares similares